Three-quarters of all psychiatric disorders occur by early adulthood (mid-20s). This fact suggests that bio-psychosocial factors occurring from the fetal period through early adulthood could play a crucial role in risk. This nonsystematic review sought to synthesize key epidemiological evidence of relevant risk factors.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist primarily used to improve glycemic control in adults with type 2 diabetes. One favorable side effect of semaglutide is weight loss, and researchers have now studied its use in adults with overweight or obesity and without diabetes.
Approximately 5% to 10% of shift workers, including many health care professionals, have shift work disorder, a circadian sleep-wake cycle disorder defined by poor quality sleep.
Author describes efficacy and safety information on red yeast rice in the treatment of dyslipidemia.
A recent review underscores the possible adverse effects of ketogenic diets including increased risks for heart disease, cancer, diabetes, and kidney stones.
Researchers used global baseline data to examine cardiovascular disease risk factors among middle-aged people with HIV.
A novel study evaluated the effect of cardiometabolic syndrome on early vascular disease in patients with psoriasis.
Concomitant treatment of common comorbidities of HS, including anxiety and depression, metabolic syndrome, and smoking, may improve treatment outcomes.
A new study confirms that the timing of meals affects cardiometabolic risk factors and the ability to lose weight.
The prevalence of comorbidities in pediatric patients with alopecia areata was determined, using a large de-identified aggregated patient database.
